Opportunity
DIBBS #SPE2DP-26-T-4805
DLA Solicitation for FDA-Regulated Linezolid Tablets, 600 mg, 20-Count Units
Posted
September 01, 2026
Respond By
September 08, 2026
Identifier
SPE2DP-26-T-4805
NAICS
424210
This opportunity from the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain seeks FDA-regulated Linezolid Tablets for military medical logistics. - Government Buyer: - Defense Logistics Agency (DLA) Troop Support Medical Supply Chain Pharm FSA - Buyer: James Foggie, Buyer Code DJF0150 - Delivery location: 51st Medical Logistics AWCF SSF, Fort Bragg, NC - OEMs and Vendors: - GREENSTONE LLC (NDC59762-1307-01) - RISING PHARMA HOLDINGS, INC. (NDC64980-0561-02) - Products Requested: - Linezolid Tablets, 600 mg, packaged in 20-count units - NSN 6505-01-483-3345 - Total quantity: 6 bottles (1, 1, and 4 bottles across three line items) - Part numbers: NDC59762-1307-01 (GREENSTONE LLC), NDC64980-0561-02 (RISING PHARMA HOLDINGS, INC.) - Unique/Notable Requirements: - FDA-regulated pharmaceutical - Packaging and marking per MIL-STD-2073-1E and Medical Marking Standard No. 1 - Compliance with domestic sourcing laws - Prohibition on covered defense telecommunications equipment - Delivery is FOB destination with a 5-day lead time after order - Required delivery to Fort Bragg, NC - Emphasis on sourcing only from approved OEMs and part numbers
Description
LINEZOLID TABLETS (QTY: 1, NSN: 6505-01-483-3345, Purchase Request: 7018111727) Approved Sources: - CAGE: 48KC0, Part No: NDC59762-1307-01, Company: GREENSTONE LLC - CAGE: 8FG82, Part No: NDC64980-0561-02, Company: RISING PHARMA HOLDINGS, INC.
LINEZOLID TABLETS (QTY: 4, NSN: 6505-01-483-3345, Purchase Request: 7018106188) Approved Sources: - CAGE: 48KC0, Part No: NDC59762-1307-01, Company: GREENSTONE LLC - CAGE: 8FG82, Part No: NDC64980-0561-02, Company: RISING PHARMA HOLDINGS, INC.
LINEZOLID TABLETS (QTY: 1, NSN: 6505-01-483-3345, Purchase Request: 7018111696) Approved Sources: - CAGE: 48KC0, Part No: NDC59762-1307-01, Company: GREENSTONE LLC - CAGE: 8FG82, Part No: NDC64980-0561-02, Company: RISING PHARMA HOLDINGS, INC.